In summary, these findings indicate that tumor cells with high IGF2BP2 expression recruit both M2‐like and SPP1+ macrophages (Figure 7O), which together may contribute to an immunosuppressive microenvironment and affect treatment outcomes. This evidence concerns the gene IGF2BP2 and neoplasm.